Genomic evolution and chemoresistance in germ-cell tumours
Amaro Taylor‐Weiner(Critical Path Institute), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Kevin Litchfield(Cancer Research UK), Anita Reddy(Valdosta State University), Anthony Letai(Dana-Farber Cancer Institute), Clare Turnbull(Institute of Cancer Research), Scott L. Carter(Broad Institute), Travis Zack(City College of San Francisco), Michelle S. Hirsch(Perinatal Institute), Rameen Beroukhim(Broad Institute), G. Celine Han(Broad Institute), Elizabeth O’Donnell(Harvard University), Stacey Gabriel(Broad Institute), Brandon Bernard(Dana-Farber Brigham Cancer Center), Ali Amin‐Mansour, Steven E. Schumacher(Broad Institute), Saud H. AlDubayan(Broad Institute), Gad Getz(Broad Institute), Jennifer L. Guerriero(Brigham and Women's Hospital), Christopher J. Sweeney(The University of Adelaide)
Cited by 171
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
The Structure of Haplotype Blocks in the Human Genome
|Science|2002|5.9k